Structure of LEO-39652

Òdual-softÓ topical PDE4 inhibitor soft drug

to treat atopic dermatitis, lack of PD in Ph. I

from metab. opt. of prev. discont. candidate

J. Med. Chem., Oct. 15, 2020

LEO Pharma, Ballerup, DK

LEO 39652 (LEO Pharma “dual-soft” topical PDE4 inhibitor soft drug clinical candidate)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.